GlassScriptPhysician profile
Jay K Levin
NPI 1326062258
$1,841.86
in general payments reported to CMS, 2019-2025
9 companies · $167 in 2025
The $167 reported for 2025 was more than what 77% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2021: $391 · 2023: $282 · 2024: $476 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $924.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $778.12 | 2019-2021 | |
| Atricure, INC. | $298.28 | 2023-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Boston Scientific Corporation | $176.89 | 2023 | Watchman Access System |
| Abbott Laboratories | $175.30 | 2024 | Amplatzer Amulet |
| Abiomed | $146.10 | 2025 | |
| La Jolla Pharmaceutical Company | $115.24 | 2019 | |
| Haemonetics Corporation | $104.60 | 2024 | Teg6s Hemostasis System |
| Johnson & Johnson Surgical Vision, INC. | $23.77 | 2019 | |
| Terumo Medical Corporation | $23.56 | 2024 | Glidewire, Angio-Seal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.